Views & Analysis ASCO 2019 and the future of oncology The future of oncology is to be showcased at ASCO 2019 when the world’s leading cancer event returns to McCormick Place in Chicago.
Views & Analysis ASCO 2019 Preview – in partnership with Kantar ASCO’s 2019 conference is due to begin in just a few days’ time, highlighting the latest cutting edge cancer drugs and technology.
News Lily gets FDA nod for SERD-CDK 4/6 combo in breast cancer Eli Lilly's imlunestrant (Inluriyo) for breast cancer has received a new FDA approval, in combination with CDK4/6 inhibitor abemaciclib (Verzenio).
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
